Status:
COMPLETED
Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2
Lead Sponsor:
Changhai Hospital
Collaborating Sponsors:
Second Military Medical University
Ministry of Education, China
Conditions:
Intestinal Diseases
Gastrointestinal Hemorrhage
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Capsule endoscopy has been shown to be the first-line endoscopic procedure for small bowel disease. This study was aimed to compare the performance between the frequency-altering AKE-1 capsule and the...
Eligibility Criteria
Inclusion
- obscure gastrointestinal bleeding
- chronic diarrhea
- suspected Crohn's disease
- chronic abdominal pain
- neoplastic lesions of small bowel
Exclusion
- patients with any contraindication to capsule endoscopy
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT01872286
Start Date
November 1 2011
End Date
February 1 2013
Last Update
March 3 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Wuhan Union Hospital
Wuhan, Hubei, China, 430022
2
Shanghai Changhai Hospital
Shanghai, Shanghai Municipality, China, 200433